YouTube magic that brings views, likes and suibscribers
Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer
Dr Thierry Conroy talks to ecancer at ASCO 2023 about the randomised phase 3 PRODIGE 23 trial.
It found that modified FOLFIRINOX chemotherapy before chemoradiation, surgery and adjuvant chemotherapy significantly improved survival outcomes in patients with locally advanced rectal cancer, versus standard of care.
Recommended
